SureTrader
Interactive Brokers Advertisement
Home > Boards > Stock Clubs > Technical Analysis >

TRADING 14 SA FOR MNKD and MU

RSS Feed
      Hide Sticky   Hide Intro
Moderator: TREND1 Assistants:
Search This Board: 
Last Post: 12/12/2017 11:16:26 AM - Followers: 3 - Board type: Premium - Posts Today: 0

TRADING SA
SureTrader
Interactive Brokers Advertisement
PostSubject
#216   12/12 MannKind Guidance Will Apparently Be As Clear TREND1 12/12/17 11:16:26 AM
#215   12/8 Spencer Osborne's Blog TREND1 12/08/17 06:43:14 PM
#214   12/6 Spencer Osborne's Blog TREND1 12/06/17 12:18:56 PM
#213   12/2 MannKind's Afrezza Scripts Dip On Holiday Week TREND1 12/02/17 11:26:34 AM
#212   12/1 MannKind - Setting The Record Straight TREND1 12/02/17 11:24:31 AM
#211   11/30 MannKind - Technical Look TREND1 11/30/17 12:09:46 PM
#210   11/30 Could The FDA's Less Stringent Regulations Help MannKind? TREND1 11/30/17 12:07:01 PM
#209   11/23 An Integrated BioSci Research On MannKind Corporation: TREND1 11/23/17 12:45:39 PM
#208   11/21 Exact Sciences, We Bid You Farewell TREND1 11/21/17 10:46:40 AM
#207   11/20 Enanta Pharmaceuticals' (ENTA) CEO Jay Luly on TREND1 11/20/17 10:31:11 PM
#206   11/20 Enanta Pharma misses by $0.27, beats on revenue TREND1 11/20/17 05:22:30 PM
#205   11/20 MannKind And Guidance TREND1 11/20/17 12:23:41 PM
#204   11/18 Exact Science: 40% Market Share? TREND1 11/18/17 12:21:53 PM
#203   11/17 EXACT Sciences (EXAS) Presents At Jefferies 2017 TREND1 11/17/17 01:36:22 PM
#202   11/16 MannKind: Insider Trading, Short Interest, And Catalysts, TREND1 11/16/17 03:03:30 PM
#201   11/14 Spencer Osborne's Blog Growth, value, special situations, momentum TREND1 11/14/17 04:09:12 PM
#200   11/14 EXACT Sciences (EXAS) Q3 2017 Results - TREND1 11/14/17 01:09:13 PM
#199   11/3 MannKind - Deferred Revenue, Revenue, And Cash TREND1 11/13/17 11:28:26 AM
#198   11/10 MannKind - Afrezza Scripts And The Special Meeting TREND1 11/11/17 03:42:10 PM
#197   11/8 MannKind Q3 Call - The Good, The TREND1 11/08/17 05:53:01 PM
#196   11/7 MannKind Earnings On Tap - What We TREND1 11/07/17 02:46:19 PM
#195   11/6 MannKind Scripts Rebound - Why The Equity TREND1 11/06/17 10:35:16 AM
#194   10/31 MannKind Isurance Update TREND1 10/31/17 01:25:49 PM
#193   10/30 MannKind: Afrezza Scripts Flat Into Q2 TREND1 10/30/17 02:47:41 PM
#192   10/24 MannKind: Debt Holders Are Bullish TREND1 10/24/17 01:27:05 PM
#191   10/23 MannKind: The Proof Is In The Pie TREND1 10/23/17 06:01:04 PM
#190   10/20 With Afrezza Sales Flat, MannKind Needs Growth TREND1 10/20/17 07:40:10 PM
#189   10/16 MannKind - Script Sales Dip To Start Q4 TREND1 10/16/17 10:35:24 AM
#188   10/10 MannKind Is A Trade Not An TREND1 10/10/17 01:27:06 PM
#186   10/9 MannKind: Rise On Affreza Label Revision Acceptance TREND1 10/09/17 10:24:58 AM
#185   10/8 MannKind - Warrant Exchange Contract TREND1 10/08/17 09:21:50 PM
#184   10/6 CHART OF ACC NEW SCRIPTS VS REFILLS TREND1 10/06/17 12:43:15 PM
#183   10/6 MannKind Is In A Race It Can't Win TREND1 10/06/17 12:07:57 PM
#182   MNKD TREND1 10/05/17 09:36:31 PM
#176   10/3 MU TREND1 10/03/17 03:55:38 PM
#175   10/2 Micron: The Endorsement Of An Icon TREND1 10/03/17 03:30:48 PM
#174   10/2 Afrezza Gets Label Change - Is It TREND1 10/03/17 10:41:56 AM
#173   10/1 MannKind Corporation to Hold Investor Conference Call TREND1 10/01/17 11:12:37 PM
#172   MNKD 10 MIN TREND1 09/28/17 09:15:15 PM
#171   9/27 MannKind: FDA Label Decision Is Almost Here TREND1 09/27/17 11:04:12 AM
#170   9/22 MannKind: Afrezza Scripts Rebound To Highest Level TREND1 09/22/17 05:23:41 PM
#169   9/14 MannKind Puts Focus On Pipeline TREND1 09/14/17 12:28:32 PM
#168   9/13 MannKind: Their Technosphere Drug Delivery System - TREND1 09/13/17 11:18:29 AM
#167   9/11 MannKind Corporation's (MNKD) CEO Michael Castagna Presents TREND1 09/11/17 06:50:15 PM
#166   9/9 MannKind - Afrezza Scripts Finish August Flat TREND1 09/09/17 11:34:15 AM
#165   9/1 MannKind: Afrezza Sales Bring In More Dollars; TREND1 09/01/17 03:11:52 PM
#164   8/25 MannKind - Scripts, Marketing, And Clinical Trials TREND1 08/25/17 04:11:29 PM
#163   8/18 MannKind - Scripts Rise, But Not Enough TREND1 08/18/17 01:02:53 PM
#162   8/8 Micron Technology Is Looking Cheap TREND1 08/08/17 11:27:06 AM
#161   8/8 MannKind's (MNKD) CEO Michael Castagna On Q2 TREND1 08/08/17 11:24:54 AM
PostSubject